Advertisement

Features Articles

Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncology drugs

MediMab Biotherapeutics Opens Bespoke Laboratory Facilities

New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumors

Advertisement

Advertisement

Advertisement

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.